Apyx Medical Return on Tangible Equity 2012-2025 | APYX
Current and historical return on tangible equity values for Apyx Medical (APYX) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Apyx Medical Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-09-30 | $-0.02B | $0.01B | -157.89% |
| 2025-06-30 | $-0.02B | $0.01B | -167.44% |
| 2025-03-31 | $-0.02B | $0.01B | -164.71% |
| 2024-12-31 | $-0.03B | $0.01B | -166.67% |
| 2024-09-30 | $-0.03B | $0.01B | -164.38% |
| 2024-06-30 | $-0.03B | $0.02B | -125.00% |
| 2024-03-31 | $-0.02B | $0.02B | -81.36% |
| 2023-12-31 | $-0.02B | $0.03B | -56.72% |
| 2023-09-30 | $-0.02B | $0.03B | -41.38% |
| 2023-06-30 | $-0.02B | $0.04B | -41.83% |
| 2023-03-31 | $-0.02B | $0.04B | -49.38% |
| 2022-12-31 | $-0.02B | $0.04B | -52.27% |
| 2022-09-30 | $-0.02B | $0.04B | -39.58% |
| 2022-06-30 | $-0.02B | $0.05B | -33.17% |
| 2022-03-31 | $-0.02B | $0.05B | -29.49% |
| 2021-12-31 | $-0.02B | $0.05B | -26.43% |
| 2021-09-30 | $-0.02B | $0.06B | -25.32% |
| 2021-06-30 | $-0.02B | $0.06B | -24.39% |
| 2021-03-31 | $-0.02B | $0.06B | -25.10% |
| 2020-12-31 | $-0.01B | $0.06B | -19.62% |
| 2020-09-30 | $-0.02B | $0.06B | -23.53% |
| 2020-06-30 | $-0.02B | $0.07B | -22.46% |
| 2020-03-31 | $-0.02B | $0.07B | -20.13% |
| 2019-12-31 | $-0.02B | $0.07B | -24.44% |
| 2019-09-30 | $-0.02B | $0.08B | -22.02% |
| 2019-06-30 | $0.06B | $0.08B | 64.71% |
| 2019-03-31 | $0.06B | $0.08B | 84.29% |
| 2018-12-31 | $0.06B | $0.09B | 117.97% |
| 2018-09-30 | $0.07B | $0.09B | 176.32% |
| 2018-06-30 | $0.00B | $0.02B | -14.46% |
| 2018-03-31 | $0.00B | $0.02B | -18.82% |
| 2017-12-31 | $-0.01B | $0.02B | -22.73% |
| 2017-09-30 | $-0.01B | $0.02B | -22.22% |
| 2017-06-30 | $-0.01B | $0.02B | -22.73% |
| 2017-03-31 | $-0.01B | $0.02B | -23.53% |
| 2016-12-31 | $-0.01B | $0.02B | -24.39% |
| 2016-09-30 | $-0.01B | $0.02B | -25.32% |
| 2016-06-30 | $-0.01B | $0.02B | -28.92% |
| 2016-03-31 | $-0.01B | $0.02B | -27.27% |
| 2015-12-31 | $0.01B | $0.02B | 39.13% |
| 2015-09-30 | $0.01B | $0.02B | 27.03% |
| 2015-06-30 | $0.00B | $0.02B | 27.12% |
| 2015-03-31 | $0.01B | $0.02B | 44.44% |
| 2014-12-31 | $-0.02B | $0.00B | -232.26% |
| 2014-09-30 | $-0.02B | $0.01B | -153.19% |
| 2014-06-30 | $-0.02B | $0.01B | -103.45% |
| 2014-03-31 | $-0.02B | $0.01B | -94.12% |
| 2013-12-31 | $-0.01B | $0.02B | -30.77% |
| 2013-09-30 | $0.00B | $0.02B | -5.00% |
| 2013-06-30 | $0.00B | $0.02B | -4.94% |
| 2013-03-31 | $0.00B | $0.02B | 0.00% |
| 2012-12-31 | $0.00B | $0.02B | 0.00% |
| 2012-09-30 | $0.00B | $0.02B | -5.00% |
| 2012-06-30 | $0.00B | $0.02B | -5.00% |
| 2012-03-31 | $0.00B | $0.02B | -5.06% |
| 2011-12-31 | $0.00B | $0.02B | -5.13% |
| 2011-09-30 | $0.00B | $0.02B | -5.19% |
| 2011-06-30 | $0.00B | $0.02B | -5.26% |
| 2011-03-31 | $0.00B | $0.02B | -5.33% |
| 2010-12-31 | $0.00B | $0.02B | -5.56% |
| 2010-09-30 | $0.00B | $0.02B | 0.00% |
| 2010-06-30 | $0.00B | $0.02B | 0.00% |
| 2010-03-31 | $0.00B | $0.02B | 0.00% |
| 2009-12-31 | $0.00B | $0.02B | 0.00% |
| 2009-09-30 | $0.00B | $0.01B | 0.00% |
| 2009-06-30 | $0.00B | $0.01B | 0.00% |
| 2009-03-31 | $0.00B | $0.01B | 7.27% |
| 2008-12-31 | $0.00B | $0.02B | 7.41% |
| 2008-09-30 | $0.00B | $0.01B | 23.08% |
| 2008-06-30 | $0.00B | $0.01B | 23.08% |
| 2008-03-31 | $0.00B | $0.01B | 23.53% |
| 2007-12-31 | $0.00B | $0.01B | 32.00% |
| 2007-09-30 | $0.00B | $0.01B | 16.67% |
| 2007-06-30 | $0.00B | $0.01B | 26.09% |
| 2007-03-31 | $0.00B | $0.01B | 27.91% |
| 2006-12-31 | $0.00B | $0.01B | 30.00% |
| 2006-09-30 | $0.00B | $0.01B | 32.43% |
| 2006-06-30 | $0.00B | $0.01B | 23.53% |
| 2006-03-31 | $0.00B | $0.01B | 12.50% |
| 2005-12-31 | $0.00B | $0.01B | 0.00% |
| 2005-09-30 | $0.00B | $0.01B | 0.00% |
| 2005-06-30 | $0.00B | $0.01B | 13.79% |
| 2005-03-31 | $0.00B | $0.01B | 13.79% |
| 2004-12-31 | $0.00B | $0.01B | 14.81% |
| 2004-09-30 | $0.00B | $0.01B | 15.38% |
| 2004-06-30 | $0.00B | $0.01B | 0.00% |
| 2004-03-31 | $0.00B | $0.01B | 0.00% |
| 2003-12-31 | $0.00B | $0.01B | 0.00% |
| 2003-09-30 | $0.00B | $0.01B | 0.00% |
| 2003-06-30 | $0.00B | $0.01B | 0.00% |
| 2003-03-31 | $0.00B | $0.01B | 0.00% |
| 2002-12-31 | $0.00B | $0.01B | 0.00% |
| 2002-09-30 | $0.00B | $0.01B | 0.00% |
| 2002-06-30 | $0.00B | $0.01B | 0.00% |
| 2002-03-31 | $0.00B | $0.01B | 0.00% |
| 2001-12-31 | $0.00B | $0.01B | 0.00% |
| 2001-09-30 | $0.00B | $0.01B | 0.00% |
| 2001-06-30 | $0.00B | $0.01B | 0.00% |
| 2001-03-31 | $0.00B | $0.01B | 0.00% |
| 2000-12-31 | $0.00B | $0.01B | 0.00% |
| 2000-09-30 | $0.00B | $0.01B | 0.00% |
| 2000-06-30 | $0.00B | $0.00B | -50.00% |
| 2000-03-31 | $0.00B | $0.00B | -47.06% |
| 1999-12-31 | $0.00B | $0.00B | -47.06% |
| 1999-09-30 | $0.00B | $0.00B | -70.59% |
| 1998-12-31 | $0.00B | $0.00B | -25.00% |
| 1998-03-31 | $0.00B | $0.00B | 0.00% |
| 1997-12-31 | $0.00B | $0.00B | 0.00% |
| 1997-09-30 | $0.00B | $0.00B | 0.00% |
| 1997-06-30 | $0.00B | $0.00B | 0.00% |
| 1997-03-31 | $0.00B | $0.00B | 0.00% |
| 1996-12-31 | $0.00B | $0.00B | 0.00% |
| 1996-06-30 | $0.00B | $0.00B | 0.00% |
| 1995-09-30 | $0.00B | $0.00B | 0.00% |
| 1993-03-31 | $0.00B | $0.00B | 100.00% |
| 1992-12-31 | $0.00B | $0.00B | 133.33% |
| 1992-09-30 | $0.00B | $0.00B | 200.00% |
| 1992-06-30 | $0.00B | $0.00B | 400.00% |
| 1992-03-31 | $0.00B | $0.00B | 0.00% |
| 1991-12-31 | $0.00B | $0.00B | 0.00% |
| 1991-09-30 | $0.00B | $0.00B | 0.00% |
| 1991-06-30 | $0.00B | $0.00B | 0.00% |
| 1991-03-31 | $0.00B | $0.00B | 0.00% |
| 1990-12-31 | $0.00B | $0.00B | 0.00% |
| 1990-09-30 | $0.00B | $0.00B | -400.00% |
| 1990-06-30 | $0.00B | $0.00B | -200.00% |
| 1990-03-31 | $0.00B | $0.00B | -133.33% |
| 1989-12-31 | $0.00B | $0.00B | -133.33% |
| 1989-09-30 | $0.00B | $0.00B | -200.00% |
| 1989-06-30 | $0.00B | $0.00B | -400.00% |
| 1988-12-31 | $0.00B | $0.00B | 400.00% |
| 1988-09-30 | $0.00B | $0.00B | 400.00% |
| 1988-03-31 | $0.00B | $0.00B | 0.00% |
| 1987-12-31 | $0.00B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.151B | $0.048B |
| Apyx Medical Corporation is an energy technology company. It provides products in the cosmetic and surgical markets. The company's Helium Plasma Technology is marketed and sold as Renuvion(R) in the cosmetic surgery market and J-Plasma(R) in the hospital surgical market. Apyx Medical Corporation, formerly known as Bovie Medical Corporation, is based in FL, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $189.676B | 21.18 |
| EssilorLuxottica (ESLOY) | France | $140.849B | 0.00 |
| Stryker (SYK) | United States | $138.598B | 26.59 |
| Medtronic (MDT) | Ireland | $131.983B | 18.29 |
| Boston Scientific (BSX) | United States | $115.097B | 25.46 |
| Medline (MDLN) | United States | $60.694B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.604B | 0.00 |
| ResMed (RMD) | United States | $38.903B | 25.98 |
| GE HealthCare Technologies (GEHC) | United States | $37.513B | 17.97 |
| Agilent Technologies (A) | United States | $36.753B | 23.23 |
| Koninklijke Philips (PHG) | Netherlands | $27.809B | 18.16 |
| Terumo (TRUMY) | Japan | $18.896B | 21.35 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.585B | 10.97 |
| Insulet (PODD) | United States | $17.105B | 53.09 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.943B | 0.00 |
| Baxter (BAX) | United States | $11.191B | 9.03 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.080B | 29.05 |
| Demant (WILYY) | Denmark | $6.521B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.301B | 13.10 |
| Envista Holdings (NVST) | United States | $4.063B | 20.59 |
| BillionToOne (BLLN) | United States | $3.897B | 0.00 |
| ICU Medical (ICUI) | United States | $3.694B | 23.45 |
| Prestige Consumer Healthcare (PBH) | United States | $3.152B | 14.63 |
| Haemonetics (HAE) | United States | $3.044B | 13.22 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.014B | 0.00 |
| Neogen (NEOG) | United States | $2.304B | 50.43 |
| Phibro Animal Health (PAHC) | United States | $2.027B | 17.86 |
| LeMaitre Vascular (LMAT) | United States | $1.973B | 39.72 |
| Perrigo (PRGO) | Ireland | $1.964B | 4.92 |
| QuidelOrtho (QDEL) | United States | $1.949B | 12.53 |
| AtriCure (ATRC) | United States | $1.800B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.466B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.466B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.421B | 20.57 |
| Green Thumb Industries (GTBIF) | United States | $1.417B | 62.09 |
| BioLife Solutions (BLFS) | United States | $1.060B | 314.57 |
| Capricor Therapeutics (CAPR) | United States | $1.053B | 0.00 |
| Lumexa Imaging Holdings (LMRI) | United States | $0.959B | 0.00 |
| InMode (INMD) | Israel | $0.937B | 10.59 |
| Tilray Brands (TLRY) | Canada | $0.821B | 0.00 |
| Valneva SE (VALN) | France | $0.803B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.790B | 0.00 |
| Omeros (OMER) | United States | $0.761B | 0.00 |
| CeriBell (CBLL) | United States | $0.717B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.578B | 15.66 |
| Verano Holdings (VRNO) | United States | $0.447B | 0.00 |
| Cerus (CERS) | United States | $0.411B | 0.00 |
| Brainsway (BWAY) | Israel | $0.410B | 69.77 |
| Canopy Growth (CGC) | Canada | $0.398B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.361B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.326B | 26.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Evolus (EOLS) | United States | $0.286B | 0.00 |
| Quanterix (QTRX) | United States | $0.275B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.234B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.219B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Utah Medical Products (UTMD) | United States | $0.201B | 18.06 |
| Organigram Global (OGI) | Canada | $0.200B | 0.00 |
| High Tide (HITI) | Canada | $0.200B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.196B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.191B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.188B | 55.17 |
| Sanara MedTech (SMTI) | United States | $0.178B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.175B | 0.00 |
| Accendra Health (ACH) | United States | $0.170B | 1.71 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.146B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.129B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.69 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.104B | 0.00 |
| Biote (BTMD) | United States | $0.097B | 4.24 |
| Exagen (XGN) | United States | $0.076B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 23.49 |
| Sharps Technology (STSS) | United States | $0.041B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 29.85 |
| Cytosorbents (CTSO) | United States | $0.040B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.039B | 0.00 |
| Veru (VERU) | United States | $0.036B | 0.00 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| United-Guardian (UG) | United States | $0.033B | 16.63 |
| Jin Medical (ZJYL) | China | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.019B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| INLIF (INLF) | China | $0.010B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| ZeroStack (ZSTK) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Agape ATP (ATPC) | $0.003B | 0.00 | |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |